Nephrogenex Inc (NRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | NRX | GLMD | UPC | ||
Company | Nephrogenex Inc | Galmed Pharmaceutica | Universe Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.12 | 2.96 | 1.88 | ||
High | 0.16 | 2.96 | 1.96 | ||
Low | 0.12 | 2.76 | 1.80 | ||
Last | 0.14 | 2.89 | 1.82 | ||
Change | +0.01 | +0.02 | -0.20 | ||
% Change | +7.69% | +0.75% | -9.90% | ||
Volume | 822,900 | 19,039 | 118,462 | ||
20-Day Average Volume | 663,825 | 50,130 | 116,647 | ||
Previous Close | 0.13 | 2.87 | 2.02 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.35 | 2.93 | 2.45 | ||
20-Day Raw Stochastic | 5.13% | 15.56% | 6.68% | ||
20-Day Relative Strength | 33.39% | 42.03% | 26.14% | ||
Weighted Alpha | -91.19 | -63.82 | -79.16 | ||
Today's Opinion | N/A | 100% Sell | 100% Sell | ||
Previous Opinion | N/A | 100% Sell | 100% Sell | ||
Last Month's Opinion | N/A | 56% Sell | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 05/03/16 | -2.44% since 11/26/24 | +2.21% since 11/26/24 | ||
Low | 0.10 on 05/09/16 | 2.71 on 11/27/24 | 1.67 on 12/02/24 | ||
High | 0.19 on 05/05/16 | 3.10 on 12/02/24 | 2.60 on 12/02/24 | ||
1-Month | |||||
%Chg | -70.21% since 04/08/16 | -13.58% since 11/04/24 | -55.98% since 11/04/24 | ||
Low | 0.10 on 05/09/16 | 2.68 on 11/25/24 | 1.67 on 12/02/24 | ||
High | 0.88 on 04/26/16 | 3.45 on 11/06/24 | 4.37 on 11/06/24 | ||
3-Month | |||||
%Chg | -85.26% since 02/10/16 | -0.36% since 09/04/24 | -95.92% since 09/04/24 | ||
Low | 0.10 on 05/09/16 | 2.68 on 11/25/24 | 1.67 on 12/02/24 | ||
High | 1.20 on 02/22/16 | 23.80 on 09/17/24 | 50.10 on 09/11/24 | ||
6-Month | |||||
%Chg | -93.94% since 11/10/15 | -36.94% since 06/04/24 | -94.44% since 06/04/24 | ||
Low | 0.10 on 05/09/16 | 2.68 on 11/25/24 | 1.67 on 12/02/24 | ||
High | 2.85 on 12/14/15 | 23.80 on 09/17/24 | 64.80 on 07/09/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,680 | 1,848 | 488 | ||
Shares Outstanding, K | 12,950 | 644 | 242 | ||
Annual Sales | 0 | 0 | 32,310,000 | ||
Annual Net Income | -22,860,000 | -6,910,000 | -6,160,000 | ||
Last Quarter Sales | N/A | 0 | N/A | ||
Last Quarter Net Income | N/A | -1,910,000 | N/A | ||
60-Month Beta | 0.57 | 0.75 | 1.25 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -2.31 on 11/14/24 | N/A | ||
Latest Earnings Date | 05/11/16 | 11/27/24 | 04/30/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |